Angina, Stable Clinical Trials

13 recruitingLast updated: June 18, 2026

There are 13 actively recruiting angina, stable clinical trials across 8 countries. Studies span Not Applicable, Phase 4. Top locations include London, United Kingdom, Portsmouth, United Kingdom, Basildon, United Kingdom. Updated daily from ClinicalTrials.gov.


Angina, Stable Trials at a Glance

13 actively recruiting trials for angina, stable are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in London, Portsmouth, and Basildon. Lead sponsors running angina, stable studies include Luzerner Kantonsspital, Imperial College London, and Fundacion Investigacion Interhospitalaria Cardiovascular.

Browse angina, stable trials by phase

Treatments under study

About Angina, Stable Clinical Trials

Looking for clinical trials for Angina, Stable? There are currently 13 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Angina, Stable trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Angina, Stable clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting

Advanced Invasive Diagnosis Strategy for Post-PCI Patients With Stable Coronary Syndromes Undergoing Coronary Angiography

Chronic Coronary SyndromeAngina, StablePercutaneous Coronary Intervention (PCI)+1 more
Fundacion Investigacion Interhospitalaria Cardiovascular246 enrolled5 locationsNCT07638137
Recruiting
Not Applicable

iCorMicA - Stratified Medicine in Angina

Coronary Artery DiseaseCoronary Microvascular Dysfunction (CMD)Angina, Stable+7 more
NHS Greater Glasgow and Clyde1,500 enrolled39 locationsNCT04674449
Recruiting
Not Applicable

Aerobic Exercise-induced Effect on Endothelial Function in Patients With Ischaemic Heart Disease

Cardiorespiratory FitnessAcute Myocardial InfarctionAngina, Stable+3 more
Instituto de Investigación Sanitaria y Biomédica de Alicante132 enrolled2 locationsNCT06788275
Recruiting
Not Applicable

Study of Lesion-Specific Invasive Haemodynamic Angina Thresholds

Coronary Artery Disease (CAD)Angina, StableIschaemic Heart Desease
Imperial College London60 enrolled6 locationsNCT07386418
Recruiting
Not Applicable

Advanced NanoTherapies Dual-API DCB to Treat De-Novo and ISR Lesions in Patients With Symptomatic Coronary Artery Disease

Angina, StableCAD - Coronary Artery DiseaseNSTEMI - Non-ST Segment Elevation MI+1 more
Advanced NanoTherapies30 enrolled3 locationsNCT07368933
Recruiting
Not Applicable

Artificial Intelligence in ANOCA

Angina, Stable
UMC Utrecht250 enrolled1 locationNCT06387693
Recruiting
Not Applicable

MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation

Heart TransplantMyocardial InfarctionCoronary Artery Disease+3 more
University of California, San Francisco516 enrolled5 locationsNCT05933083
Recruiting
Phase 4

Effect of Beta-blockers on Coronary Flow and Resistance in Patients With ANOCA

Coronary Arterial Disease (CAD)Angina, StableMicrovascular Circulation
VZW Cardiovascular Research Center Aalst46 enrolled1 locationNCT06864234
Recruiting

Biochemical and Electrocardiographic Signatures in the Detection of Exercise-induced Myocardial Ischemia

SPECTCoronary Artery DiseaseAngina, Stable+2 more
University Hospital, Basel, Switzerland4,000 enrolled1 locationNCT01838148
Recruiting
Not Applicable

Effects of Acupuncture on Symptoms of Stable Angina

Angina, Stable
University of California, Los Angeles112 enrolled1 locationNCT06311461
Recruiting

COMPLEX Registry - a Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting with CompLEX and Calcified Coronary Artery Disease

Coronary RestenosisCoronary DiseaseCoronary Artery Disease+7 more
Luzerner Kantonsspital5,000 enrolled1 locationNCT06075602
Recruiting

SIROOP Registry - A Prospective Registry Study to Evaluate the Outcomes of Coronary Artery Disease Patients Treated With SIROlimus Or Paclitaxel Eluting Balloon Catheters

Coronary RestenosisCoronary DiseaseCoronary Artery Disease+7 more
Luzerner Kantonsspital2,000 enrolled1 locationNCT04988685
Recruiting

Influence of Air Quality on the Development and Progression of Premature Coronary Artery Disease

Acute Coronary SyndromeMyocardial InfarctionAngina, Stable+2 more
pablo Juan-Salvadores4,272 enrolled1 locationNCT06464042